Evidence for the risk of calcium channel blockers in hypertension was selective

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7067.1259c (Published 16 November 1996) Cite this as: BMJ 1996;313:1259
  1. Fahmy W F Hanna,
  2. John R Peters,
  3. J Alan Rees
  1. Senior registrar Consultant physician Consultant physician University Hospital of Wales, Cardiff CF4 4XN

    EDITOR,—We have five comments on the Fortnightly review by D G Beevers and P Sleight.1

    Firstly, Beevers and Sleight say that results from a Chinese study may not be readily applicable to a Western population and that a longer acting formulation of nifedipine was used.2 It could be argued that if a beneficial effect was demonstrable in a population with low incidence of an event then it would be similar, if not more beneficial, in a population …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription